Fortress Biotech Inc.
(FBIOP)
undefined
undefined%
At close: undefined
6.98
0.00%
After-hours Dec 13, 2024, 03:44 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
Net Income | -60.64M | -213.91M | -164.83M | -102.98M | -101.66M | -130.80M | -99.84M | -71.29M | -53.88M | -20.39M | -37.16M | -27.61M | -36.36M | -9.98M |
Depreciation & Amortization | 6.00M | 9.35M | 6.79M | 5.33M | 4.65M | 2.06M | 3.35M | 1.13M | 26.00K | 23.00K | 17.00K | 3.00K | 22.00K | 5.00K |
Stock-Based Compensation | 17.03M | 22.99M | 19.49M | 13.45M | 13.19M | 15.01M | 14.01M | 12.13M | 14.29M | 5.55M | 5.90M | 3.64M | 1.47M | 2.33M |
Other Working Capital | -4.61M | -5.43M | 756.00K | -4.90M | 1.53M | -680.00K | -6.24M | -1.39M | -701.00K | -684.00K | -127.00K | -138.00K | 1.82M | -89.00K |
Other Non-Cash Items | -78.09M | 2.89M | 24.43M | 10.49M | 12.05M | 8.86M | 7.84M | 10.32M | 11.89M | 236.00K | 536.00K | 1.17M | -14.20M | 1.42M |
Deferred Income Tax | - | - | -38.80M | -5.18M | -18.35M | 287.00K | -8.56M | -73.00K | 2.11M | -220.00K | - | - | 36.34M | 234.00K |
Change in Working Capital | -12.52M | -715.00K | 36.37M | -4.78M | -4.84M | 5.74M | -2.23M | 1.97M | 5.19M | -1.53M | 1.06M | -398.00K | 1.77M | 318.00K |
Operating Cash Flow | -128.22M | -179.40M | -116.54M | -83.68M | -94.96M | -98.85M | -85.43M | -45.81M | -20.38M | -16.33M | -29.65M | -23.19M | -10.95M | -5.68M |
Capital Expenditures | -63.00K | -3.06M | -16.35M | -7.16M | -9.39M | -9.36M | -5.45M | -10.51M | -11.98M | - | -188.00K | -279.00K | -3.84M | -13.00K |
Acquisitions | - | -20.00M | 56.86M | - | -1.20M | 2.27M | -19.00K | 4.45M | -11.70M | - | - | - | - | - |
Purchase of Investments | - | - | - | - | -5.00M | -52.60M | -56.09M | -181.00K | -79.95M | -23.27M | - | - | - | - |
Sales Maturities Of Investments | - | - | - | - | 22.60M | 71.00M | 20.09M | - | 99.95M | - | - | - | - | - |
Other Investing Acitivies | -2.04M | 127.00K | 45.08M | -5.24M | 13.09M | 7.51M | -163.00K | -6.00K | 11.56M | -23.27M | -188.00K | -279.00K | -3.84M | -13.00K |
Investing Cash Flow | -2.10M | -22.93M | 40.51M | -7.16M | 20.10M | 18.82M | -41.63M | -6.06M | 7.88M | -23.27M | -188.00K | -279.00K | -3.84M | -13.00K |
Debt Repayment | -36.85M | 49.25M | -9.64M | -29.67M | 15.00M | 17.30M | 37.16M | 6.14M | 10.00M | 355.00K | -1.34M | 14.25M | - | -348.00K |
Common Stock Repurchased | -400.00K | - | - | -70.00K | - | - | - | - | - | - | - | - | - | -2.29M |
Dividend Paid | -8.77M | -8.78M | -8.78M | -6.75M | -2.56M | -2.34M | -299.00K | - | - | - | - | - | - | - |
Other Financial Acitivies | -2.02M | -4.30M | 12.16M | 38.30M | 5.21M | -2.57M | 18.40M | -3.33M | -6.90M | -14.01M | -836.00K | -2.59M | 48.68M | 19.39M |
Financial Cash Flow | 32.74M | 75.32M | 148.99M | 172.41M | 146.71M | 50.65M | 154.21M | 41.98M | 60.92M | -10.15M | 89.16M | 40.51M | 23.09M | 19.04M |
Net Cash Flow | -97.59M | -127.01M | 72.97M | 81.56M | 71.85M | -29.38M | 27.15M | -9.89M | 48.42M | -49.76M | 59.32M | 17.04M | 8.30M | 13.35M |
Free Cash Flow | -136.32M | -182.46M | -132.89M | -90.85M | -104.36M | -108.20M | -90.88M | -56.32M | -32.36M | -16.33M | -29.83M | -23.47M | -14.79M | -5.69M |